证券日报网讯2月9日，三博脑科（301293）发布公告称，公司于2026年2月8日收到内蒙古自治区监察委 员会签发的《解除责令候查通知书》，相关部门已解除对张阳先生的责令候查措施。目前，公司正常经 营，张阳先生正常履职。 ...

Core Viewpoint - The China Securities Medical Index (399989) closed at 7161.62 points, up 0.6%, with a trading volume of 19.192 billion yuan and a turnover rate of 1.97% on February 9 [1] Group 1: Index Performance - On the same day, 37 of the index's constituent stocks rose, with Sanbo Brain Science leading with a 5.32% increase, while 12 stocks declined, with Aier Eye Hospital falling by 2.98% [1] - The top ten constituent stocks of the China Securities Medical Index are primarily in the pharmaceutical and medical sectors, with WuXi AppTec holding the highest weight at 10.03% [1] Group 2: Stock Details - The top ten stocks include: - WuXi AppTec: Weight 10.03%, Latest Price 98.70, Market Cap 294.97 billion yuan [1] - Mindray Medical: Weight 9.12%, Latest Price 189.17, Market Cap 229.36 billion yuan [1] - United Imaging Healthcare: Weight 7.49%, Latest Price 128.92, Market Cap 106.25 billion yuan [1] - Aier Medical: Weight 6.04%, Latest Price 10.74, Market Cap 100.16 billion yuan [1] - Other notable stocks include Tigermed, Kanglong Chemical, and Yuyue Medical, all within the medical and pharmaceutical industry [1] Group 3: Capital Flow - The net outflow of main funds from the index's constituent stocks totaled 205 million yuan, while retail investors saw a net inflow of 1.51 billion yuan [1] - Detailed capital flow indicates that major stocks like WuXi AppTec and Mindray Medical experienced varying levels of net inflow and outflow from different investor categories [2]

Group 1: Financing Measures and Market Reactions - The Shanghai and Shenzhen Stock Exchanges announced a package of measures to optimize refinancing, aiming to support high-quality listed companies and improve refinancing efficiency [1] - The domestic gold jewelry prices have rebounded, with prices reaching 1555-1560 RMB per gram [1] - The lithium carbonate market saw a rebound with prices increasing by over 5% due to improved market sentiment [1] Group 2: Price Adjustments and Market Trends - Major global PC manufacturers, including Lenovo and HP, have initiated price increases due to rising upstream storage costs, with some products seeing price hikes of over 600 RMB in a single day [2] - The storage industry is projected to see significant growth, with its value expected to reach 551.6 billion USD, surpassing that of the wafer foundry sector [2] Group 3: Corporate Developments - The company Dingxin Communications faced penalties for short-term trading by its executive, resulting in a fine of 120,000 RMB [7] - Sanbo Brain Science announced the lifting of a supervisory order against its chairman, allowing normal operations to resume [8] - Jinwei Co. plans to acquire 100% of Fusheng Mining for 210 million RMB, expanding its mining operations [10] Group 4: Project Wins and Acquisitions - Yitong Century won a bid for a project worth 107 million RMB to provide comprehensive maintenance services for China Tower [11] - Jida Communication is expected to receive approximately 51 million RMB from a project with China Mobile [12] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for 864 million RMB [13] Group 5: Financial Performance - Qianjin Pharmaceutical reported a slight revenue increase of 0.13% for 2025, with a net profit growth of 24.74% [17] - Dongwei Technology achieved a significant net profit growth of 86.81% for 2025, with total revenue increasing by 47.65% [18] Group 6: Market Performance - The market saw a strong performance with the ChiNext Index rising nearly 3%, driven by AI applications and other sectors [20]

Group 1 - XianDao Intelligent has set the final price for its H-share public offering at HKD 45.8 per share, with expected listing on February 11, 2026 [1] - Jida Communication is a candidate for a project with China Mobile, with an estimated service fee of approximately CNY 51.04 million [2] - Bowei Alloy's controlling shareholder plans to increase holdings by CNY 100 million to 150 million from February 10 to August 9, 2026 [3] Group 2 - Xiamen Airport reported 16,368 aircraft takeoffs and landings in January 2026, a year-on-year decrease of 4.82%, with passenger throughput of 2.38 million, down 3.84% [4] - Yitong Century has won a bid for a project worth CNY 107 million, providing comprehensive maintenance services for China Tower [5] - Huayi Brothers' controlling shareholder's 70 million shares are subject to judicial auction, representing 42.89% of his holdings and 2.52% of the company's total shares [6] Group 3 - Lianhuan Pharmaceutical received approval for the sale of Tadalafil tablets (20mg) in Ghana [7] - Aonong Biological reported a pig sales volume of 166,600 in January 2026, a year-on-year increase of 35.36% [8] - Xiantan Co. achieved chicken product sales revenue of CNY 546 million in January 2026, a year-on-year increase of 54.9% [9] Group 4 - Zhengbang Technology reported a January sales revenue of CNY 816 million from pig sales, a year-on-year increase of 19.69% [10] - Qianjin Pharmaceutical's net profit for 2025 grew by 24.74% to CNY 288 million [11] - Xinhua Pharmaceutical received a drug registration certificate for glucosamine sulfate capsules [12] Group 5 - Yuandong Bio completed the first dosing of its EP-0210 monoclonal antibody in a Phase I clinical trial for inflammatory bowel disease [13] - Jiaokong Technology signed a contract for the Sydney Metro West Line signal system subcontracting project worth AUD 93.53 million [14] - Dangsheng Technology signed a strategic cooperation framework agreement with Huineng Technology in solid-state batteries and the new energy industry [15] Group 6 - Jinhui Co. plans to acquire 100% of Fusheng Mining for CNY 210 million [16] - Cangzhou Mingzhu announced Guangzhou Light Industry as its new controlling shareholder after a share transfer [17] - Dingxin Technology's vice president was fined CNY 120,000 for short-term trading [18][19] Group 7 - China Modern Pharmaceutical's subsidiary passed a GMP compliance inspection for its production line [20] - Chaosheng Electronics plans to increase capital by CNY 400 million in its subsidiary to enhance competitiveness [21] - Lonyu Mountain reported a 25.03% year-on-year increase in pig sales revenue in January 2026 [22] Group 8 - Sanbo Brain Science's chairman has been released from investigation, and the company is operating normally [23] - Hainan Mining is planning to acquire control of Luoyang Fengrui Fluorine Industry and will resume trading on February 10, 2026 [24] - Dongwei Technology's net profit for 2025 increased by 86.81% [25] Group 9 - Yuanjie Technology plans to invest CNY 1.251 billion in a semiconductor chip and device R&D production base [26] - Metro Design signed a contract for an energy management project with Guangzhou Metro Group worth CNY 924 million [27] - Zhongmin Energy intends to acquire 51% of Fujian Yongtai Mintou Pumped Storage Co. for CNY 864 million [28] Group 10 - Dianzhi Technology plans to repurchase shares worth CNY 100 million to 200 million [29] - China Baoan was not selected as a restructuring investor for the Singshan Group [30] - Zhiguang Electric's subsidiary signed a CNY 1.004 billion contract for energy storage systems [31] Group 11 - Zhifei Biological received approval for a clinical trial of its herpes zoster vaccine [32] - KQ Bio received a new veterinary drug registration certificate for a vaccine against porcine circovirus type 2 [33] - Huanxu Electronics reported a 4% year-on-year increase in consolidated revenue for January 2026 [34] Group 12 - Xiangjia Co. reported a 10.42% year-on-year increase in live poultry sales revenue in January 2026 [35] - Kemin Foods' subsidiary reported a 68.29% year-on-year increase in pig sales revenue in January 2026 [36] - Liyuan Technology signed a procurement contract worth CNY 54.98 million [37] Group 13 - Jiuqiang Bio received a medical device registration certificate for a fibrin degradation product detection kit [38] - Zhongguancun's subsidiary passed the consistency evaluation for Tramadol Hydrochloride tablets [39] - Rundou Co. received a drug registration certificate for Candesartan Etil [40]

Mergers and Acquisitions - Jinwei Co., Ltd. plans to acquire 100% equity of Fusheng Mining for a cash consideration of 210 million yuan, which will make Fusheng Mining a wholly-owned subsidiary [2] - Zhongmin Energy intends to acquire 51% equity of Fuzhou Investment Pumped Storage Co., Ltd. for 864 million yuan, based on an asset evaluation report [4] - Hainan Mining is planning to acquire 69.9% equity of Fengrui Fluorine Industry through a combination of issuing shares and cash payments, with the aim to expand its fluorite mining business [9] Corporate Announcements - Sanbo Brain Science announced that one of its actual controllers, Zhang Yang, has had the investigation measures lifted, allowing him to resume normal duties [3] - China Baoan stated that it was not selected as a restructuring investor for the merger of Shanshan Group and its subsidiary, and will receive a refund of the due diligence deposit [6] - Dongwei Technology reported a significant increase in net profit for 2025, reaching 129 million yuan, driven by growth in PCB equipment orders [11] Financial Performance - Qianjin Pharmaceutical reported a net profit of 288 million yuan for 2025, a year-on-year increase of 24.74%, attributed to stable revenue growth from core industrial enterprises [10] - Weimaisi announced a net profit of 557 million yuan for 2025, up 39.22%, despite a slight decline in total revenue [12] Strategic Partnerships - Dingsheng Technology signed a strategic cooperation framework agreement with Huineng Technology to enhance collaboration in solid-state batteries and the new energy industry [7] Stock Movements - Hengdian Film and Television reported a significant stock price increase of 83.98% over the past 10 trading days, raising concerns about potential overvaluation and market speculation risks [8]

三博脑科（301293）(301293.SZ)发布公告，公司于2026年2月8日收到内蒙古自治区监察委员会签发的 《解除责令候查通知书》，相关部门已解除对张阳先生的责令候查措施。目前，公司正常经营，张阳先 生正常履职。 ...

智通财经APP讯，三博脑科(301293.SZ)发布公告，公司于2026年2月8日收到内蒙古自治区监察委员会签 发的《解除责令候查通知书》，相关部门已解除对张阳先生的责令候查措施。目前，公司正常经营，张 阳先生正常履职。 ...

公司于2026年2月8日收到内蒙古自治区监察委员会签发的《解除责令候查通知书》，相关部门已解除对 张阳先生的责令候查措施。目前，公司正常经营，张阳先生正常履职。 格隆汇2月9日丨三博脑科(301293.SZ)公布，2025年7月22日，公司披露了《关于控股股东、实际控制人 之一暨董事长解除留置并变更为责令候查的公告》，相关部门解除了对张阳先生的留置措施，变更为责 令候查措施。 ...

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 证券代码：301293 证券简称：三博脑科 公告编号：2026-006 三博脑科医院管理集团股份有限公司 关于控股股东、实际控制人之一暨董事长解除责令候查的 公告 公司指定的信息披露媒体为《证券时报》《证券日报》《中国证券报》《上 海证券报》《经济参考报》和巨潮资讯网（www.cninfo.com.cn），公司发布的信 息均以在上述指定媒体刊登的信息为准。敬请广大投资者理性投资，注意投资风 险。 三博脑科医院管理集团股份有限公司董事会 2026 年 2 月 9 日 1 三博脑科医院管理集团股份有限公司（以下简称"公司"）于 2025 年 4 月 21 日披露了《关于控股股东、实际控制人之一暨董事长被留置和立案调查的公 告》（公告编号：2025-022），公司控股股东、实际控制人之一暨董事长张阳先 生被内蒙古自治区监察委员会实施留置、立案调查。 2025 年 7 月 22 日，公司披露了《关于控股股东、实际控制人之一暨董事长 解除留置并变更为责令候查的公告》（公告编号：2025-027），相关部门解除了 对张阳先生 ...

证券研究报告 Neuralink带来的启示 ——脑机接口系列报告 行业评级：看好（维持） n Neuralink带来新启示：脑机接口有望成为人与机器交流的首选，触达更广阔市场。 n 脑机接口国内政策与产业窗口期共振，中国临床案例数大幅提升。 n 脑机接口与大模型、具身智能技术深入融合，大幅推进应用落地速度。 2 2026年2月 分析师 刘雯蜀 分析师 郑毅 分析师 刘静一 邮箱 liuwenshu03@stocke.com.cn 邮箱 zhengyi@stocke.com.cn 邮箱 liujingyi@stocke.com.cn 证书编号 S1230523020002 证书编号 S1230524070002 证书编号 S1230523070005 • 核心观点 Ø Neuralink的首款产品Telepathy（心灵感应）预计在今年量产，目前超10000人申请体验。Telepathy聚焦 "大脑功能正常，但运动 / 交流通路断裂" 的重症群体，例如脊髓损伤、渐冻症患者。量产的三个重要条件——N1性能提升、手术安全性提升、成本降低：1）预计2026年N1设备电极数量从 1000 个增加到 3000 个，提升神 ...